Dachaigh › Lymphoma Hodgkin
Sgrùdaidhean clionaigeach Lymphoma Hodgkin a’ fastadh anns na SA
Tha 62 sgrùdaidhean airson Lymphoma Hodgkin a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Houston, TX14 sgrùdaidhean
- New York City, NY11 sgrùdadh
- Baldwin Park, CA9 sgrùdaidhean
- Boston, MA9 sgrùdaidhean
- Miami, FL8 sgrùdaidhean
- Memphis, TN7 sgrùdaidhean
- Philadelphia, PA6 sgrùdaidhean
- Atlanta, GA5 sgrùdaidhean
- Mountain View, CA5 sgrùdaidhean
- Greenburgh, NY5 sgrùdaidhean
- Durham, NC4 sgrùdaidhean
- Milwaukee, WI4 sgrùdaidhean
- Edison, NJ4 sgrùdaidhean
- Queens, NY4 sgrùdaidhean
- Aurora, CO4 sgrùdaidhean
- Washington, DC4 sgrùdaidhean
- Madison, WI4 sgrùdaidhean
- Los Angeles, CA3 sgrùdaidhean
- San Francisco, CA3 sgrùdaidhean
- Sacramento, CA3 sgrùdaidhean
- Baltimore, MD3 sgrùdaidhean
- Staten Island, NY3 sgrùdaidhean
- New Rochelle, NY3 sgrùdaidhean
- East Norwalk, CT3 sgrùdaidhean
- Columbus, OH3 sgrùdaidhean
- Denver, CO3 sgrùdaidhean
- Orange, CA3 sgrùdaidhean
- Seattle, WA3 sgrùdaidhean
- Cincinnati, OH3 sgrùdaidhean
- Chicago, IL3 sgrùdaidhean
- Indianapolis, IN3 sgrùdaidhean
- Minneapolis, MN3 sgrùdaidhean
Le stàit
- California15 sgrùdaidhean
- Colorado5 sgrùdaidhean
- Florida12 sgrùdaidhean
- Georgia7 sgrùdaidhean
- Illinois4 sgrùdaidhean
- Indiana4 sgrùdaidhean
- Maryland5 sgrùdaidhean
- Massachusetts9 sgrùdaidhean
- Minnesota4 sgrùdaidhean
- New Jersey5 sgrùdaidhean
- New York15 sgrùdaidhean
- North Carolina6 sgrùdaidhean
- Ohio4 sgrùdaidhean
- Pennsylvania7 sgrùdaidhean
- Tennessee8 sgrùdaidhean
- Texas15 sgrùdaidhean
- Washington4 sgrùdaidhean
- Wisconsin8 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
A’ fastadhÌre 1 tràth
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06398457Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
A’ fastadhÌre 1
Aoisean 12 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06176690CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)
A’ fastadhÌre 1
Aoisean 12 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT02917083Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
A’ fastadhSgrùdadh amharc
Aoisean 0 gu 38 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06131801The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07285044Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT03418038Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT02682667Tissue Collection for Studies of Lymph Cancer
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT01676805Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT03618550A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT05615636Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
A’ fastadhÌre 1
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT05798897AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
A’ fastadhÌre 1/2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT06137144Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT05272384Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies
A’ fastadhÌre 1
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT07444632Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT06421987Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL
A’ fastadhÌre 2
Aoisean 2 gu 21 · Gach gnè · Air ùrachadh 31 Lùna 2026 · NCT07551583Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
A’ fastadh
Gach aois · Gach gnè · Air ùrachadh 21 Lùna 2026 · NCT07514819ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT07021989CD45BE-HSPC + CART-45 Cells
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT07451054Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
A’ fastadhÌre 1/2
Aoisean 12 gu 80 · Gach gnè · Air ùrachadh 7 Lùna 2026 · NCT05092451ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT06090864Personalized NK Cell Therapy in CBT
A’ fastadhÌre 2
Aoisean 15 gu 80 · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT02727803A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 28 Iuch 2026 · NCT07020533A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Iuch 2026 · NCT06150664Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Iuch 2026 · NCT06580002Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.